Full Paper
130.2, 134.1, 149.2, 149.9, 155.1, 190.8 ppm (eight signals were
missing, possibly because of signal overlap); HRMS (ESI): calcd for
C39H60O6+: m/z 624.4390; found: 624.4425 [M]+.
was washed with brine (20 mL) and concentrated. The residue was
dissolved in isopropyl alcohol (14 mL) and CH2Cl2 (42 mL) and then
NaBH4 (62 mg, 1.64 mmol) was added to the reaction mixture,
which was stirred at room temperature for 2 h. The organic sol-
vents were then evaporated under reduced pressure. The residue
was partitioned between CHCl3 (3ꢁ50 mL) and H2O (50 mL). The
combined organic phases were washed with brine (50 mL), dried
(MgSO4), and concentrated. The residue was purified chromato-
graphically on SiO2 (CH2Cl2/MeOH (99:1)) to afford a white solid
(475 mg, 21%). M.p. 133–1348C; 1H NMR (400 MHz, CDCl3, 298 K):
d=1.20–1.36 (m, 84H), 1.38–1.51 (m, 24H), 1.59 (t, J=5.6 Hz, 3H),
1.68–1.81 (m, 24H), 3.46 (d, J=13.6 Hz, 3H), 3.82–4.03 (m, 24H),
4.57 (d, J=5.6 Hz, 6H), 4.68 (d, J=13.6 Hz, 3H), 6.76–6.87 (m, 12H),
6.89 ppm (s, 3H); 13C NMR (100 MHz, CDCl3, 298 K): d=26.3, 26.4,
26.4, 29.6, 29.6, 29.6, 29.8, 29.8, 29.9, 36.4, 65.3, 69.2, 69.4, 69.6,
113.1, 114.0, 116.1, 116.1, 119.6, 132.3, 133.8, 147.9, 148.0, 148.9,
149.5 ppm (15 signals were missing, possibly because of signal
overlap); HRMS (ESI): calcd for C120H186O15Na: m/z 1890.3689;
found: 1890.3622 [M+Na]+.
Triol 12: A solution of macrocycle 10 (1.86 g, 2.98 mmol) and
Sc(OTf)3 (146 mg, 297 mmol) in CHCl3 (54 mL) and CH3NO2 (6 mL)
was heated under reflux for 16 h. After cooling to room tempera-
ture, water (30 mL) was added to the mixture. The organic phase
was washed with brine (30 mL) and concentrated. The residue was
dissolved in isopropyl alcohol (8 mL) and CH2Cl2 (24 mL) and then
NaBH4 (42 mg, 1.11 mmol) was added to the reaction mixture,
which was stirred at room temperature for 2 h. The organic sol-
vents were then evaporated under reduced pressure. The residue
was partitioned between CHCl3 (3ꢁ50 mL) and H2O (50 mL). The
combined organic phases were washed with brine (50 mL), dried
(MgSO4), and concentrated. The residue was purified chromato-
graphically on SiO2 (CH2Cl2/MeOH (99:1)) to afford triol 12 as
a white solid (350 mg, 19%). M.p. 114–1158C; 1H NMR (400 MHz,
CDCl3, 298 K): d=1.22–1.35 (m, 78H), 1.37–1.51 (m, 24H), 1.68–1.80
(m, 24H), 3.46 (d, J=13.6 Hz, 3H), 3.82–4.00 (m, 24H), 4.56 (s, 6H),
4.68 (d, J=13.6 Hz, 3H), 6.78–6.85 (m, 12H), 6.89 ppm (s, 3H);
13C NMR (100 MHz, CDCl3, 298 K): d=26.3, 26.4, 26.4, 29.6, 29.7,
29.8, 29.9, 30.0, 36.5, 65.4, 69.2, 69.6, 69.8, 113.0, 114.2, 115.9, 116.3,
119.6, 132.2, 132.3, 133.9, 147.9, 148.0, 148.9, 149.6 ppm (14 signals
were missing, possibly because of signal overlap) HRMS (ESI): calcd
for C117H180O15+: m/z 1825.3322; found: 1825.3373 [M]+.
Molecular cage 3: A solution of the triol 13 (475 mg, 254 mmol) in
CHCl3 (20 mL) was added to a solution of TFA (12.7 mL) in CHCl3
(200 mL) and CH3NO2 (50 mL) over a period of 12 h and then the
mixture was stirred at room temperature for 60 h. After the addi-
tion of saturated Na2CO3(aq) (100 mL), the organic phase was
washed with brine (100 mL), dried (MgSO4), and concentrated. The
residue was purified chromatographically on SiO2 (from CH2Cl2 to
CH2Cl2/MeOH (200:1)) to afford a white solid, which was recrystal-
lized (CH2Cl2/hexanes) to give 3 (73.7 mg, 16%). M.p. 248–2498C;
1H NMR (400 MHz, CDCl3, 298 K): d=1.14–1.47 (m, 108H), 1.60–1.93
(m, 24H), 3.46 (d, J=13.6 Hz, 6H), 3.76–3.90 (m, 12H), 3.96–4.08
(m, 12H), 4.68 (d, J=13.6 Hz, 6H), 6.77 (s, 6H), 6.82 ppm (s, 6H);
13C NMR (100 MHz, CDCl3, 298 K): d=25.9, 26.4, 29.0, 29.4, 29.8,
30.2, 30.5, 36.4, 68.2, 70.3, 114.4, 117.1, 131.7, 132.7, 147.3,
148.1 ppm (four signals were missing, possibly because of signal
overlap); HRMS (ESI): calcd for C120H180O12: m/z 1813.3475; found:
1813.3495 [M]+.
Molecular cage 2: A solution of triol 12 (296 mg, 162 mmol) in
CHCl3 (45 mL) was added to a solution of trifluoroacetic acid (TFA;
8.1 mL) in CHCl3 (85 mL) and CH3NO2 (32 mL) over a period of 12 h
and then the mixture was stirred at room temperature for 60 h.
After the addition of saturated Na2CO3(aq) (100 mL), the organic
phase was washed with brine (100 mL), dried (MgSO4), and concen-
trated. The residue was purified chromatographically on SiO2 (from
CH2Cl2 to CH2Cl2/MeOH (200:1)) to afford a white solid, which was
recrystallized (CH2Cl2/hexanes) to give 2 (29.5 mg, 16%). M.p. 267–
2688C; 1H NMR (400 MHz, CDCl3, 298 K): d=1.14–1.45 (m, 102H),
1.60–1.84 (m, 24H), 3.45 (d, J=13.6 Hz, 6H), 3.76–3.90 (m, 12H),
3.98–4.10 (m, 12H), 4.68 (d, J=13.6 Hz, 6H), 6.76 (s, 6H), 6.82 ppm
(s, 6H); 13C NMR (100 MHz, CDCl3, 298 K): d=26.4, 26.5, 29.1, 29.2,
29.5, 29.7, 29.9, 30.1, 30.5, 30.5, 36.4, 68.2, 70.0, 113.8, 116.5, 131.4,
Hemicarceplex C76@2: A solution of the molecular cage 2 (21 mg,
18 mmol) and C76 (11 mg, 12 mmol) in CHCl2CHCl2 (6 mL) was stirred
at 358C for 30 h and then the solvent was evaporated under re-
duced pressure. The solid residue was purified chromatographically
on SiO2 (CS2 then CH2Cl2/hexanes (4:1)) to afford hemicarceplex
C76@2 as a black solid (15 mg, 48%). 1H NMR (400 MHz, CDCl2CDCl2,
298 K): d=1.17–1.55 (m, 102H), 1.68–1.94 (m, 24H), 3.50 (d, J=
132.5, 147.1, 148.1 ppm (one signals was missing, possibly because
+
of signal overlap); HRMS (ESI): calcd for C117H174O12
z 1771.3005; found: 1771.3946 [M]+.
: m/
Macrocycle 11: A mixture of triol 7 (6.67 g, 15.0 mmol), 1,14-dibro-
motetradecane (5.34 g, 15.0 mmol), and K2CO3 (16.6 g, 120 mmol)
in DMF (1500 mL) was stirred at 508C for 5 days and then the sol-
vent was evaporated under reduced pressure. The residue was par-
titioned between CHCl3 (4ꢁ250 mL) and H2O (400 mL). The com-
bined organic phases were dried (MgSO4) and concentrated. The
residue was purified chromatographically on SiO2 (CH2Cl2/MeOH
(100:0.5)) to afford a white solid (2.27 g, 24%). M.p. 149–1508C;
1H NMR (400 MHz, CDCl3, 323 K): d=1.21–1.39 (m, 28H), 1.45–1.54
(m, 8H), 1.73–1.87 (m, 8H), 3.94–4.09 (m, 8H), 4.58 (d, J=6.0 Hz,
2H), 6.81–6.87 (m, 2H), 6.89–6.95 (m, 2H), 7.35–7.43 (m, 2H),
9.80 ppm (s, 1H); 13C NMR (100 MHz, CDCl3, 323 K): d=26.2, 26.3,
26.4, 29.2, 29.3, 29.4, 29.5, 29.6, 29.6, 29.7, 29.7, 29.8, 29.8, 29.8,
29.9, 65.4, 69.0, 69.2, 69.3, 69.4, 111.2, 111.8, 113.1, 114.0, 119.6,
126.6, 129.9, 133.8, 149.5, 149.6, 154.9, 191.0 ppm (eight signals
were missing, possibly because of signal overlap); HRMS (ESI):
calcd for C40H62O6Na: m/z 661.4444; found: 661.4420 [M+Na]+.
13.6 Hz, 6H), 3.66–3.82 (m, 12H), 3.95–4.10 (m, 12H), 4.74 (d, J=
+
13.6 Hz, 6H), 6.76 ppm (s, 12H); HRMS (ESI): calcd for C193H174O12
m/z 2683.3000; found: 2683.2757 [M]+.
:
Hemicarceplex C78@2: A solution of the molecular cage 2 (15 mg,
13 mmol) and C78 (8 mg, 9 mmol) in CHCl2CHCl2 (4 mL) was stirred
at 358C for 30 h and then the solvent was evaporated under re-
duced pressure. The solid residue was purified chromatographically
on SiO2 (CS2 then CH2Cl2/hexanes (4:1)) to afford hemicarceplex
C78@2 as a black solid (16 mg, 67%). 1H NMR (400 MHz, CDCl2CDCl2,
298 K): d=1.14–1.57 (m, 102H), 1.69–1.93 (m, 24H), 3.33 (d, J=
14.0 Hz, 1.3H), 3.42 (d, J=13.6 Hz, 3.1H), 3.56–3.84 (m, 13.6H),
3.91–4.10 (m, 12H), 4.57 (d, J=14.0 Hz, 1.3H), 4.66 (d, J=13.6 Hz,
3.1H), 4.84 (d, J=13.6 Hz, 1.6H), 6.56 (s, 2.6H), 6.66 (s, 6.2H),
+
6.87 ppm (s, 3.2H); HRMS (ESI): calcd for C195H174O12
z 2707.3000; found: 2707.3005 [M]+.
: m/
Hemicarceplex C84@3: A solution of the molecular cage 3 (16 mg,
9 mmol) and C84 (6 mg, 6 mmol) in CHCl2CHCl2 (3 mL) was stirred at
358C for 30 h and then the solvent was evaporated under reduced
pressure. The solid residue was purified chromatographically on
SiO2 (CS2 then CH2Cl2/hexanes (4:1)) to afford hemicarceplex C84@3
Triol 13: A solution of macrocycle 11 (2.27 g, 3.55 mmol) and
Sc(OTf)3 (87 mg, 0.177 mmol) in CHCl3 (35 mL) and CH3NO2 (3.5 mL)
was heated under reflux for 16 h. After cooling to room tempera-
ture, water (20 mL) was added to the mixture. The organic phase
Chem. Eur. J. 2016, 22, 1 – 10
7
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
&
&
These are not the final page numbers! ÞÞ